|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
EBSCO_ocn958984939 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
160923s2016 nyu o 000 0 eng d |
| 040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d EBLCP
|d OCLCF
|d MFS
|d SNK
|d DKU
|d AUW
|d INTCL
|d IGB
|d D6H
|d VTS
|d AGLDB
|d G3B
|d YDX
|d S8J
|d S9I
|d STF
|d OCLCQ
|d OCLCO
|d OCLCQ
|
| 019 |
|
|
|a 965759738
|
| 020 |
|
|
|a 9781634852067
|q (electronic bk.)
|
| 020 |
|
|
|a 1634852060
|q (electronic bk.)
|
| 020 |
|
|
|z 9781634851725
|
| 020 |
|
|
|z 1634851722
|
| 035 |
|
|
|a (OCoLC)958984939
|z (OCoLC)965759738
|
| 050 |
|
4 |
|a RC523
|b .R43 2016eb
|
| 060 |
|
4 |
|a WT 155
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.831
|2 23
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Research progress in Alzheimer's disease and dementia.
|n Volume 6 /
|c Miao-Kun Sun, Editor.
|
| 264 |
|
1 |
|a New York :
|b Nova Biomedical,
|c [2016]
|
| 300 |
|
|
|a 1 online resource (viii, 255 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a RESEARCH PROGRESS IN ALZHEIMER'S DISEASE AND DEMENTIA VOLUME 6; RESEARCH PROGRESS IN ALZHEIMER'S DISEASE AND DEMENTIA VOLUME 6; Library of Congress Cataloging-in-Publication Data; CONTENTS; PREFACE; Chapter 1: "LOSS OF THE FUTURE": PROSPECTION IMPAIRMENTS IN THE DEMENTIAS; ABSTRACT; ABBREVIATIONS; 1. INTRODUCTION; 1.1. The Many Functions of Memory Retrieval; 1.2. Episodic Memory as a Constructive Endeavor; 1.3. What Is Prospection?; 1.4. Assessment of Prospection; 2. CHANGES IN PROSPECTION IN HEALTHY AGING; 3. EVIDENCE FOR PERVASIVE FUTURE THINKING DEFICITS IN DEMENTIA
|
| 505 |
8 |
|
|a 3.1. Alzheimer's Disease3.1.1. Similarities across Past and Future Contexts in AD; 3.1.2. Neural Correlates of Prospection Deficits in AD; 3.1.3. Scene Construction in AD; 3.2. Amnestic Mild Cognitive Impairment; 3.2.1. Future Directions for Prospection Research In AD and aMCI; 3.3. Semantic Dementia; 3.3.1. Functional Neuroimaging of Future Simulation in SD; 3.3.2. Vulnerability of Contextual Details during Future Simulation in SD; 3.3.3. Reconfiguring of Details during Prospection; 3.4. Behavioral-Variant Frontotemporal Dementia; 3.5. Parkinson's Disease
|
| 505 |
8 |
|
|a 3.6. Relationship between Prospection and Functional Impairment in Dementia3.6.1. Prospective Memory in Neurodegenerative Disorders; 3.6.2. Decision-Making Capacity and Prospection in Dementia; 3.6.3. How Loss of the Future Impacts the Self in Dementia; CONCLUSION; ACKNOWLEDGMENTS; REFERENCES; Chapter 2: MEMORY BINDING IN ALZHEIMER'S DISEASE; ABSTRACT; ABBREVIATIONS; 1. INTRODUCTION; 2. THE BINDING PROBLEM; 3. TYPES OF BINDING; 4. MEMORY BINDING IN HEALTHY AGING AND AD; 4.1. Memory Binding in Healthy Aging; 4.2. Memory Binding in AD; 5. MEMORY BINDING IN THE EARLY DIAGNOSIS OF AD
|
| 505 |
8 |
|
|a 6. MEMORY BINDING IN THE DIFFERENTIAL DIAGNOSIS OF AD6.1. Studies in Depression; 6.2. Study in Non-AD Dementias; 7. MEMORY BINDING AND THE BRAIN: INSIGHTS INTO THE AD PATHOLOGY; 8. MEMORY BINDING AND PREVENTION INITIATIVES FOR AD; CONCLUSION; ACKNOWLEDGMENTS; REFERENCES; Chapter 3: ALZHEIMER'S DISEASE THERAPY TARGETING BACE1 AND NEPRILYSIN; ABSTRACT; ABBREVIATIONS; 1. INTRODUCTION; 2. APP PROCESSING, Ab PRODUCTION AND Ab DEGRADATION; 3. PRECLINICAL TESTING OF THERAPEUTIC BACE1 INHIBITION; 3.1. Memory Rescue by BACE1 Null Knockout in APP Mice; 3.2. Phenotypes of BACE1 Null Knockout per se
|
| 505 |
8 |
|
|a 3.3. BACE1 Haploinsufficiency3.4. Benefits of BACE1 Haploinsufficiency Lessen in APP Mice with Disease Progression; 3.5. BACE1 Inhibitors; 3.6. Strategies to Block BACE1-Elevating Pathways; 3.7. Other Approaches to Inhibit BACE1 Processing of APP; 4. PRECLINICAL TESTING OF THERAPEUTIC NEPRILYSIN ACTIVATION; 4.1. Transgenic Overexpression of Neprilysin; 4.2. Gene Transfer and Pharmacological Strategies to Elevate Neprilysin Expression; 5. PRECLINICAL TESTING OF COMBINATION Ab-LOWERING THERAPIES; CONCLUSION; ACKNOWLEDGMENTS; REFERENCES; Chapter 4: ADVANCES IN TAU IMMUNOTHERAPY; ABSTRACT
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Alzheimer's disease.
|
| 650 |
|
2 |
|a Alzheimer Disease
|
| 650 |
|
6 |
|a Maladie d'Alzheimer.
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a Alzheimer's disease.
|2 fast
|0 (OCoLC)fst00806532
|
| 700 |
1 |
|
|a Sun, Miao-Kun,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Research progress in Alzheimer's disease and dementia. Volume 6.
|d New York : Nova Biomedical, [2016]
|z 9781634851725
|w (OCoLC)957521778
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1356698
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL4698065
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 1356698
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 12933107
|
| 994 |
|
|
|a 92
|b IZTAP
|
